A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease

Treatment beyond progressive disease (PD) is a concept that even after drugs become ineffective, their continued use is more beneficial for patients than their discontinuation. In recent years, a concept of bevacizumab beyond PD (BBP) has attracted attention in the treatment of various cancers, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Tadahiro, Eto, Hisashi, Sato, Takanori, Soma, Rikako, Fukagawa, Daisuke, Tomabechi, Hidetoshi, Takatori, Eriko, Nagasawa, Takayuki, Sato, Seiya, Kagabu, Masahiro, Baba, Tsukasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787582/
https://www.ncbi.nlm.nih.gov/pubmed/31546963
http://dx.doi.org/10.3390/healthcare7030109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787582/
https://www.ncbi.nlm.nih.gov/pubmed/31546963
http://dx.doi.org/10.3390/healthcare7030109

Ejemplares similares